GENINUS Inc. (KOSDAQ: A389030)
Health Care · Biotechnology · KR
₩1,650.00
-15.38% today · -16.7% 1Y
GENINUS Inc. (KOSDAQ: A389030) operates in the Biotechnology industry within the Health Care sector. The company is valued at $48.75M.
Over the last twelve months the share price has lost 16.7%, trading between 1.55K and 6.48K.
Tweenvest scores GENINUS Inc. across four factors: quality 45/100, value 58/100. Its strongest factor is value.
A389030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.75M
- Revenue (TTM)
- $7.28M
- P/E
- —
- EPS
- -597.19
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- ₩6,480.00
- 52-week low
- ₩1,555.00
- Avg volume (3M)
- —
- Shares outstanding
- 39.39M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PanGen Biotech Inc.KOSDAQ: A222110 | $49.11M | ₩4,845.00 | +3.75% |
| Xspray Pharma AB (publ)OM: XSPRAY | $48.91M | Skr10.24 | -0.58% |
| Amicogen, Inc.KOSDAQ: A092040 | $48.83M | ₩924.00 | -6.29% |
| Optipharm.CO.,LTDKOSDAQ: A153710 | $48.80M | ₩4,435.00 | -1.22% |
| Connect Biopharma Holdings LimitedNasdaqGM: CNTB | $48.27M | $0.77 | +0.58% |
| MiNK Therapeutics, Inc.NasdaqCM: INKT | $48.02M | $9.41 | -12.22% |
| HLB Panagene Co., Ltd.KOSDAQ: A046210 | $47.81M | ₩1,400.00 | -21.08% |
| Sangamo Therapeutics, Inc.OTCPK: SGMO.Q | $47.64M | $0.12 | +9.52% |
Figures last refreshed Oct 18, 2026.